SALT LAKE CITY, May 11, 2017 /PRNewswire/ -- ProLung, Inc., the leader in innovative predictive analytics technologyand non-invasive tests for the risk stratification of lung cancer, announced today the promotion of Ryan Snow as the Director of Marketing and Business Development. Mr. Snow has been with the Company for three years and
"We are excited for Ryan to fulfill his new role as Director of Business Development during this time of rapid growth for the Company," said Steve Eror, President and CEO of ProLung. "Ryan brings a unique perspective and skill set as we approach global markets and regulatory approval in the US. He has extraordinary international experience that has been transformative for the businesses he supports."
Mr. Snow received his B.S. degree in Business and Accountancy from the University of Utah David Eccles School of Business. While attending the David Eccles School of Business he was a Student Director at the Lassonde Entrepreneur Institute. Through this experience, he realized his passion for entrepreneurism and commercialization of innovative technologies and solutions. Ryan speaks Spanish and holds international development and sales experience.
About ProLung, Inc.
ProLung's mission is to make a difference in time for lung cancer patients. ProLung is the leader in innovative predictive analytics technology and non-invasive tests for the risk stratification of lung cancer. The Company develops, tests, and commercializes solutions which may shorten the time to diagnosis and expand the therapeutic window for lung cancer patients. ProLung's predictive analytics platform for lung cancer risk stratification is approved for sale in the European Economic Area and for investigational use only in the US.
For further information, contact:Ryan Snow | +1-801-503-9231 | email@example.comDirector of Marketing and Business Development
Investor relations information, contact:Jennifer K. Zimmons, Ph.D.| +1-917-214-3514 | firstname.lastname@example.org Zimmons International Communications, Inc.
ProLung757 E. South Temple Suite 150Salt Lake City, Utah 84102USAwww.prolunginc.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/prolung-names-director-of-marketing-and-business-development-300456329.html
SOURCE ProLung, Inc.
Subscribe to our Free Newsletters!
Fallot's tetralogy is a rare and complex birth defect of the heart. Babies born with this condition ...
Bubonic plague is an infectious disease caused by the bacteria Yersinia pestis present in rodents ...
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...View All